Abstract:Fluorescence imaging technology has gradually become a new and promising tool for in vivo visualization detection. Because it can provide real-time sub-cellular resolution imaging results, it can be widely used in the field of biological detection and medical detection and treatment. However, due to the limited imaging depth (1-2 mm) and self-fluorescence background of tissue emitted in the visible region (400-700 nm), it fails to reveal biological complexity in deep tissues. The traditional near infrared wavelength (NIR-I, 650-950 nm) is considered as the first biological window, because it reduces the NIR absorption and scattering from blood and water in organisms. NIR fluorescence bioimaging's penetration is larger than that of visible light. In fact, NIR-I fluorescence bioimaging is still interfered by tissue autofluorescence (background noise), and the existence of photon scattering, which limits the depth of tissue penetration. Recent experimental and simulation results show that the signal-to-noise ratio (SNR) of bioimaging can be significantly improved at the second region near infrared (NIR-II, 1,000-1,700 nm), also known as the second biological window. NIR-II bioimaging is able to explore deep-tissues information in the range of centimeter, and to obtain micron-level resolution at the millimeter depth, which surpass the performance of NIR-I fluorescence imaging. The key of fluorescence bioimaging is to achieve highly selective imaging thanks to the functional/targeting contrast agent (probe). However, the progress of NIR-II probes is very limited. To date, there are a few reports about NIR-II fluorescence probes, such as carbon nanotubes, Ag2S quantum dots, and organic small molecular dyes. In this paper, we surveyed the development of NIR-II imaging contrast agents and their application in cancer imaging, medical detection, vascular bioimaging, and cancer diagnosis. In addition, the hotspots and challenges of NIR-II bioimaging are discussed. It is expected that our findings will lay a foundation for further theoretical research and practical application of NIR-II bioimaging, as well as the inspiration of new ideas in this field.

Recent Advances of Versatile Fluorophores for Multifunctional Biomedical Imaging in the NIR-II Region

Recent Advances in Second Near-Infrared Region (NIR-II) Fluorophores and Biomedical Applications

Advanced Fluorescence Imaging Technology in the Near-Infrared-II Window for Biomedical Applications

Recent Advances on Activatable NIR‐II Fluorescence Probes for Biomedical Imaging

Design of NIR-II High Performance Organic Small Molecule Fluorescent Probes and Summary of Their Biomedical Applications

NIR-II Fluorophores: from Synthesis to Biological Applications

In vivo NIR-II fluorescence imaging for biology and medicine

Versatile Types of Inorganic/Organic NIR-IIa/IIb Fluorophores: From Strategic Design toward Molecular Imaging and Theranostics

Recent Progress in Fluorescence Imaging of the NIR-II Window.

Advances on <i>in vivo</i> Fluorescence Bioimaging in the Second Near-Infrared Window

Recent Progress in Fluorescence Imaging of the Near‐Infrared II Window

The Fluorescence in Vivo Wide-Field Microscopic Imaging Technology and Application in the Second Near-Infrared Region

The Near-Infrared-II Fluorophores and Advanced Microscopy Technologies Development and Application in Bioimaging.

Near-infrared fluorophores for biomedical imaging

NIR-II Fluorescence in Vivo Functional Bioimaging

Near-Infrared-II (NIR-II) Bioimaging via Off-Peak NIR-I Fluorescence Emission

Advances in Lanthanide‐Based NIR‐IIb Probes for In Vivo Biomedical Imaging

Progress of NIR-II fluorescence imaging technology applied to disease diagnosis and treatment

Recent Progress In Nir-Ii Contrast Agent For Biological Imaging

Near-Infrared-II Fluorescence Probes Based on Organic Small Molecules

Management of fluorescent organic/inorganic nanohybrids for biomedical applications in the NIR-II region